The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by State of New Jersey Common Pension Fund D

State of New Jersey Common Pension Fund D lowered its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 32.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 70,367 shares of the medical device company’s stock after selling 33,689 shares during the period. State of New Jersey Common Pension Fund D’s holdings in Cooper Companies were worth $6,143,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in Cooper Companies by 303.0% in the first quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock valued at $2,343,723,000 after acquiring an additional 17,367,502 shares in the last quarter. Capital World Investors boosted its stake in Cooper Companies by 301.7% in the first quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock valued at $573,657,000 after acquiring an additional 4,246,519 shares in the last quarter. Janus Henderson Group PLC boosted its stake in Cooper Companies by 279.8% in the first quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock valued at $348,723,000 after acquiring an additional 2,532,186 shares in the last quarter. Impax Asset Management Group plc boosted its stake in Cooper Companies by 31.0% in the second quarter. Impax Asset Management Group plc now owns 2,359,798 shares of the medical device company’s stock valued at $205,511,000 after acquiring an additional 558,886 shares in the last quarter. Finally, Bessemer Group Inc. boosted its stake in Cooper Companies by 305.2% in the first quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company’s stock valued at $203,013,000 after acquiring an additional 1,507,049 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Trading Up 1.5 %

NASDAQ COO opened at $110.53 on Monday. The stock has a market capitalization of $22.01 billion, a P/E ratio of 65.02, a P/E/G ratio of 2.60 and a beta of 0.98. The Cooper Companies, Inc. has a 52-week low of $75.93 and a 52-week high of $110.69. The firm has a 50-day moving average price of $95.59 and a 200 day moving average price of $95.09. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The company had revenue of $1 billion during the quarter, compared to analysts’ expectations of $997.30 million. During the same period last year, the company posted $0.84 earnings per share. The firm’s quarterly revenue was up 7.8% compared to the same quarter last year. Equities research analysts expect that The Cooper Companies, Inc. will post 3.66 EPS for the current year.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, COO Daniel G. Mcbride sold 114,992 shares of the stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the transaction, the chief operating officer now directly owns 44,696 shares of the company’s stock, valued at $4,714,534.08. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, CAO Agostino Ricupati sold 1,601 shares of the firm’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the completion of the transaction, the chief accounting officer now directly owns 4,818 shares of the company’s stock, valued at approximately $520,488.54. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Daniel G. Mcbride sold 114,992 shares of the firm’s stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the transaction, the chief operating officer now directly owns 44,696 shares of the company’s stock, valued at $4,714,534.08. The disclosure for this sale can be found here. Over the last three months, insiders sold 141,381 shares of company stock valued at $14,927,361. Corporate insiders own 2.00% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have issued reports on COO shares. Wells Fargo & Company upped their price objective on shares of Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Stifel Nicolaus reiterated a “buy” rating and set a $115.00 target price (up previously from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Morgan Stanley increased their target price on shares of Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a research note on Tuesday, September 10th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th. Finally, Jefferies Financial Group upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and increased their target price for the stock from $107.00 to $115.00 in a research note on Tuesday, July 16th. Four equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to MarketBeat.com, Cooper Companies has an average rating of “Moderate Buy” and a consensus price target of $115.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.